Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
An 18-year-old man has been arrested on suspicion of murder following the death of a teenage girl in the Dinnington area of Rotherham.
Her son helped her in what has been termed an "honour" killing.
Donald Trump misdirected his followers to a UK council worker who has revealed her politics could not be further from the next US president.